Obsessive-compulsive spectrum disorders: Cross-national and ethnic issues

CNS Spectrums

Volumn 12, Issue 5, 2007, Pages 392-400

  Matsunaga, Hisato ^a   Seedat, Soraya ^b  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOMIPRAMINE; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR;

ADD ON THERAPY; ANOREXIA NERVOSA; ANXIETY DISORDER; BEHAVIOR THERAPY; BODY DYSMORPHIC DISORDER; BRAIN MAPPING; CLINICAL FEATURE; COGNITIVE DEFECT; COMORBIDITY; COMPULSIVE PERSONALITY DISORDER; CONTINUING EDUCATION; CULTURAL FACTOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EATING DISORDER; ETHNIC GROUP; FAMILY HISTORY; GENERALIZED ANXIETY DISORDER; GILLES DE LA TOURETTE SYNDROME; HUMAN; HYPOCHONDRIASIS; IMPULSE CONTROL DISORDER; INTERMITTENT EXPLOSIVE DISORDER; MAJOR DEPRESSION; MENTAL DISEASE; MOOD DISORDER; NEUROBIOLOGY; OBSESSIVE COMPULSIVE DISORDER; ONSET AGE; PANIC; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOPHARMACOTHERAPY; REVIEW; SOCIAL PHOBIA; SYMPTOM; TRICHOTILLOMANIA;

EID: 34249906183     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900021180     Document Type: Review

References (99)

1. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association: 1994.
2. Sasson Y, Zohar J, Chopra M, Lustig M, Iancu I, Hendler T. Epidemiology of obsessive-compulsive disorder: a world view. J Clin Psychiatry. 1997;58(suppl 12):7-10.
3. Eisen JL, Rasmussen SA. Phenomenology of obsessive-compulsive disorder. In: Stein DJ, Hollander E, eds. Pathogenesis of Obsessive-Compulsive Disorder. Textbook of Anxiety Disorders. Washington, DC: American Psychiatric Association; 2002:173-189.
4. de Silva P. Culture and obsessive-compulsive disorder. Psychiatry. 2006;5:402-404.
5. Shama BP. Obsessive-compulsive neurosis in Nepal. Transcult Psychiatr Res Rev. 1968;5:38-41.
6. Khanna S, Channabasavanna SM. Phenomenology of obsessions in obsessive-compulsive neurosis. Psychopathology. 1988;21:12-18.
7. Honjo S, Hirano C, Murase S, et al. Obsessive-compulsive symptoms in childhood and adolescence. Acta Psychiatr Scand. 1989;80:83-91.
8. Mahgoub OM, Abdel-Hafeiz HB. Pattern of obsessive-compulsive disorder in Eastern Saudi Arabia. Br J Psychiatry. 1991;158:840-842.
9. Okasha A, Saad A, Khalil AH, el Dawla AS, Yehia N. Phenomenology of obsessive compulsive disorder: A transcultural study. Compr Psychiatry. 1994;35:191-197.
10. Tukel R, Polat A, Ozdemir O, Aksut D, Turksoy N. Comorbid conditions in obsessive-compulsive disorder. Compr Psychiatry. 2002;43:204-209.
11. Fontenelle LF Mendlowicz MV Marques C, Versioni M. Trans-cultural aspects of obsessive-compulsive disorder: a description of a Brazilian sample and a systematic review of international clinical studies. J Psychiatr Res. 2004;38:403-411.
12. Hollender E, Wong CM. Obsessive-compulsive spectrum disorders. J Clin Psychiatry. 1995;56(suppl 4):3-6.
13. Weissman MM, Bland RC, Canino GJ, et al. The cross national epidemiology of obsessive-compulsive disorder. The Cross National Collaborative Group. J Clin Psychiatry. 1994;55(suppl):5-10.
14. Matsunage H, Matsui T, Ohya K, et al. An examination of homogeneity in patients with contamination obsessions and washing compulsions using a manifest symptom-based typology [Japanese]. Seishin Igaku (Clin Psychiatry). 2002;44:885-892.
15. Pigott TA, L'Heureux F, Dubbert B Bernstein S, Murphy DL. Obsessive compulsive disorder: comorbid conditions. J Clin Psychiatry. 1994;55(suppl):15-27.
16. Hollander E, Wong CM. Spectrum, boundary, and subtyping issues: implications for treatment refractory obsessive-compulsive disorder. In: Goodman WK, Rudorfer MV, Maser JD, eds. Obsessive-Compulsive Disorder Contemporary Issues in Treatment. Mahwah, NJ: Lawrence Erlbaum Associates; 2000:3-22.
17. Baer L, Jenike MA, Black DW Treece C, Rosenfeld R, Greist J. Effect of axis II disorders on treatment outcome with clomipramine in 55 patients with obsessive-compulsive disorder. Arch Gen Psychiatry. 1992;49:862-866.
18. McDougle CJ Goodman WK, Leckman JF Barr LC Heninger GR, Price LH. The efficacy of fluvoxamine in obsessive compulsive disorder: effects of comorbid chronic tic disorder. J Clin Psychopharmacol. 1993;13:354-358.
19. Dertesen J. Sociocultural and economic backgrounds of personality disorders. In: Derkesen J. ed. Personality Disorders Clinical and Social Perspectives. Chichester, UK: John Willy & Sons. 1995:279-305.
20. Stoll AL, Tonen M, Baldessarini RJ. Increasing frequency of the diagnosis of obsessive-compulsive disorder. Am J Psychiatry. 1992;149:638-640.
21. Fontenelle LF, Mendlowicz MV, Versiani M. The descriptive epidemiology of obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:327-337.
22. Robins LN, Helzer JE, Orvaschel H et al. The diagnostic interview schedule. In: Eaton WW, Kessler LG, eds. Epidemiologic Field Methods in Psychiatry: The NIMH Epidemiologic Catchment Area Program. Orlando, FL: Academic Press; 1985:143-168.
23. Myers JK, Weissman MM, Tischler GL, et al. Six-month prevalence of psychiatric disorders in three communities 1980 to 1982. Arch Gen Psychiatry. 1984;41:959-967.
24. Robins LN, Helzer JE, Weissman MM. et al. Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry. 1984;41:949-958.
25. Stefansson JG, Lindal E, Bjornsson JK. Guomundsdottir A. Lifetime prevalence of specific mental disorders among people born in Island in 1931. Acta Psychiatr Scand. 1991;84:142-149.
26. Chen CN, Wong J, Lea N, Chen-Ho MW Lau JT, Fung M. The Shatin community montal health survey in Hong Kong II major findings. Arch Gen Psychiatry. 1993;50:125-133.
27. Nemeth A, Szadoczky E, Teuer T, et al. Epidemiology of OCD in Hungary. Eur Neuropsychopharmacol. 1997;7(suppl 2):S234.
28. Robins LN, Wing J, Wittchen HU, et al. The Composite International Diagnostic Interview: An epidemiologic Instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry. 1988;45:1069-1077.
29. Stein MB, Forde DR, Anderson G, Walker JR. Obsessive-compulsive disorder in the community: An epidemiologic survey with clinical reappraisal. Am J Psychiatry. 1997;154:1120-1126.
30. Bijl RV, Ravelli A, van Zessen G. Prevalence of psychiatric disorder in the general population: results of The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc Psychiatry Psychiatr Epidemiol. 1998;33:587-595.
31. Graba HJ, Meyer C, Hepke U, et al. Prevalence, quality of the life and psychosocial function in obsessive-compulsive disorder and subclinical obsessive-compulsive disorder in northern Germany. Eur Arch Psychiatry Clin Neurosci. 2000;250:262-268.
32. Henderson S, Andrews G, Hall W. Australia's mental health: an overview of the general population survey. Aust N Z J Psychiatry. 2000;34:197-205.
33. Andrade L, Walters EE, Gentil V, Laurenti R. Prevalence of ICD-10 mental disorders in a catchment area in the city of Sao Paulo, Brazil. Soc Psychiatry Psychiatr Epidemiol. 2002;37:316-325.
34. Cillicilli AS, Telcioglu M, Askin R, Kaya N, Bodur S, Kucur R. Twelve-month prevalence of obsessive-compulsive disorder in Konya, Turkey. Compr Psychiatry. 2004;45:367-374.
35. Endicott J, Spitzer RL. A diagnostic interview: the schedule for affective disorders end schizophrenia. Arch Gen Psychiatry. 1978;35:837-844.
36. Mohammadi MR, Ghanizadeh A, Rahgozar M, et al. Prevalence of obsessive-compulsive disorder in Iran. BMC Psychiatry. 2004;4:2.
37. Nestadt G, Bienvenu OJ, Cai G, Samuels J, Eaton WW. Incidence of obsessive-compulsive disorder in adults. J Nerv Ment Dis. 1998;166:401-406.
38. Matsunaga H, Kirrike N, Matsui T, et al. Gender difference in social and interpersonal features and personality disorders among Japanese patients with obsessive-compulsive disorder. Compr Psychiatry. 2000;41:266-272.
39. Mataix-Cols D, Rauch SL, Manzo PA, Jenike MA, Baer L. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Am J Psychiatry. 1999;156:1409-1416.
40. Shooka A, Al-haddad MK, Raees A. OCD in Bahrain: a phenomenological profile. Int J Soc Psychiatry. 1998;44:147-154.
41. Karadag F, Oguzhanoglu NK, Ozdel O, Atesci FC, Amuk T. OCD symptoms in a sample of Turkish patients: a phenomenologicel picture. Depress Anxiety. 2006;23:145-152.
42. Jueng YY, Liu CY. Phenomenology of obsessive-compulsive disorder in Taiwan. Psychiatry Clin Neurosci. 2001;55:623-627.
43. Tukel R, Polet A, Ozdemir O, Aksut D, Turksoy N. Comorbid conditions in obsessive compulsive disorder. Compr Psychiatry. 2002;43:204-209.
44. Horwath E, Weissman MM. The epidemiology and cross-national presentation of obsessive-compulsive disorder. Psychiatr Clin North Am. 2000;23:493-507.
45. Denys O, de Geus F, van Megen HJ, Westenberg HG. Use of factor analysis to detect potential phenotypes in obsessive-compulsive disorder. Psychiatry Res. 2004;128:273-260.
46. Lochner C, Kinnear CJ, Hammings SM, et al. Hoarding in obsessive-compulsive disorder clinical and genetic correlates. J Clin Psychiatry. 2005;66:1155-1160.
47. Fiske AP, Haslam N. Is obsessive-compulsive disorder a pathology of the human disposition to perform socially meaningful rituals? Evidence of similar content. J Nerv Ment Dis. 1997;185:211-222.
48. Ghassemzadeh H, Mojtabai R, Khamseh A, Ebrahimkhani N, Issezadagan AA, Saif-Nobakht Z. Symptoms of obsessive-compulsive disorder in a semple of Iranian patients. Int J Soc Psychiatry. 2002;48:20-28.
49. Okesha A, Omar AM, Lotaief F, Ghanem M, Seif el Dawla A, Okesha T. Comorbidity of axis I and axis II diagnoses in a sample of Egyptian patients with neurotic disorders. Compr Psychiatry. 1996;37:95-101.
50. Cansever A, Uzun O, Donmez E, Ozsahin A. The prevalence and clinical features of body dysmorphic disorder in college students: a study in a Turkish sample. Compr Psychiatry. 2003;44:60-64.
51. Bohne A, Keuthen NJ, Wilhelm S, Deckersbach T, Jenike MA. Prevalence of symptoms of body dysmorphic disorder and its correlates: a cross-cultural comparison. Psychosomatics. 2002;43:486-490.
52. Gibbon M, Spitzer RL, Williams J, First MB, eds. Structured Clinical Interview for DSM-IV Axis I Disorders. clinician version. Washington, DC: American Psychiatric Press; 1996.
53. Brown TA, Campbell LA, Lehman CL, Grisham JR, Mancill RB. Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample. J Abnorm Psychol. 2001;110:585-599.
54. Fireman B, Koran LM, Leventhal JL, Jacobson A. The prevalence of clinically recognized obsessive-compulsive disorder in a large health maintenance organization. Am J Psychiatry. 2001;158:1904-1910.
55. Nestadt G, Samuels J, Riddle MA, et al. The relationship between obsessive-compulsive disorder and anxiety and effective disorders: results from the Johns Hopkins OCD family study. Psychol Med. 2001;31:481-487.
56. Denys D, Tenney N, van Megen HJ, de Geus F, Westenberg HG. Axis I and II comorbidity in a large sample of patients with obsessive-compulsive disorder. J Affect Disord. 2004;80:155-162.
57. LaSalle VH, Cromar KR, Nelson KN, Kazuba D, Justement L, Murphy DL. Diagnostic interview assessed neuropsychiatric disorder comorbidity in 334 individuals with obsessive-compulsive disorder. Depress Anxiety. 2004;19:163-173.
58. du Toit PL, van Kradenburg J, Niehaus D, Stein DJ. Comparison of obsessive-compulsive disorder patients with and without comorbid putative obsessive-compulsive spectrum disorders using a structured clinical interview. Compr Psychiatry. 2001;42:291-300.
59. Eichstedt JA, Arnold SL. Childhood-onset obsessive-compulsive disorder: a tic-related subtype of OCD? Clin Psychol Rev. 2001;21:137-157.
60. Grant JE, Mancebo MC, Pinto A, Eisen JL, Rasmussen SA. Impulsive control disorders in adult withm obsessive-compulsive disorder. J Psychiatr Res. 2006;40:494-501.
61. Richter MA, Summerfeldt LJ, Antony MM, Swinson RP. Obsessive-compulsive spectrom conditions in obsessive-compulsive disorder and other anxiety disorders. Depress Anxiety. 2003:18:118-127.
62. Bartz JA, Hollender E. Is obsessive-compulsive disorder an anxiety disorder? Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:338-352.
63. Nestadt G, Addington A, Samuels J, et al. The identification of OCD-related sub-groups based on comorbidity. Biol Psychiatry. 2003;53:914-920.
64. Lochner C, Hemmings SMJ, Kinnear CJ, et al. Cluster analysis of obsessive-compulsive spectrum disorders in patients with obsessive-compulsive disorder: clinical and genetic correlatas. Compr Psychiatry. 2005;46:14-19.
65. Hasler G, LaSalle-Ricci VH, Ronquillo JG, et al. Obsessive-compulsive disorder symptom dimensions show specific relationships to psychiatric comorbidity. Psychiatr Res. 2005;135:121-132.
66. Leckman JF, Walker DE, Cohen DJ. Premonitory urges in Tourette's syndrome. Am J Psychiatry. 1993;150:98-102.
67. Thiel A, Broocks A, Ohlmeier M, Jacoby GE, Schussler G. Obsessive-compulsive disorder among patients with anorexia nervosa and bulimia nervosa. Am J Psychiatry. 1995;152:72-75.
68. Kaye WH. Neurobiology and genetics-anorexia nervosa, obsessional behavior, and serotonin. Psychopharmacol Bull. 1997;33:335-344.
69. Lilenfeld LR, Kaye WH, Greeno CG, et al. A controlled family study of anorexia nervose and bulimia anervosa; psychiatric disorders in first-degree relatives and affects of probend comorbidity. Arch Gen Psychiatry. 1998;55:603-610.
70. Matsui T, Matsunaga H, Iwasaki Y, et al. Comorbid major Depression in Jepenese patients with obsessive-compulsive disorder. Seishin Igaku (Clin Psychiatry). 2001;43:957-962.
71. Jaisoorya TS, Reddy YC, Srinath S. The relationship of obsessive-compulsive disorder to putative spectrum disorders: results from an Indian study. Compr Psychiatry. 2003:44:317-323.
72. Matsunaga H, Kiriike N, Matsui T, Oya K, Okino K, Stein DJ. Impulsive-control disorders in Japanese adult patients with obsessive-compulsive disorder. Compr Psychiatry. 2005;48:43-49.
73. Fontenelle LF, Mendlowicz MV, Versiani M. Impulse control disorders in patients with obsessive-compulsive disorder. Psychiatry Clin Neurosci. 2005;59:30-37.
74. Lochner C, Stein DJ. Does work on obsessive-compulsive spectrum disorders contribute to understanding the heterogeneity of obsessive-compulsive disorder? Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:353-361.
75. Matsunaga H, Kiriike N, Iwasaki Y, Miyata A, Yamagami S, Kaye WH. Clinical characteristics in patients with anorexia nervosa and obsessive-compulsive disorder. Psychol Med. 1999;29:407-414.
76. Matsunaga H, Kiriike N, Miyata A, et al. Prevalence and symptomatology of comorbid obsessive-compulsive disorder among bulimic patients. Psychiatr Clin Neurosci. 1999;53:661-666.
77. Black DW, Noyes R. Obsessive-compulsive disorder and axis II. Int Rev Psychiatry. 1997;9:111-118.
78. Ricciardi JN, Baer L, Jenike MA, Fischer SC, Sholtz D, Buttolph ML. Changes in DSM-III-R exis II diagnoses following treatment of obsessive-compulsive disorder. Am J Psychiatry. 1992;149:829-831.
79. Matsunaga H, Kiriike N, Miyata A, et al. Personality disorders in patients with obsessive compulsive disorder in Japan. Acta Psychiatr Scand. 1998;98:128-134.
80. Matsunaga H, Kiriike N, Matsui T, et al. Obsessive-compulsive disorder patients with poor insight. Compr Psychiatry. 2002;43:150-157.
81. Mataix-Cols D, van den Heuvel OA. Common and distinct neural correlates of obsessive-compulsive and related disorders. Psychiatr Clin N Am. 2006;29:391-410.
82. Ho Pian KL, van Magen HJ, Ramsey NF, et al. Decreased thalamic blood flow in obsessive-compulsive disorder patients responding to fluvoxamine. Psychiatry Res. 2005;138:89-97.
83. Nakao T, Nakagawa A, Yoshiura T, et al. Brain activation of patients with obsessive-compulsive disorder during neuropsychological and symptom provocation tasks before and after symptom improvement a functional magnetic resonance imaging study. Biol Psychiatry. 2005;57:901-910.
84. Cavallini MC, Di Balla D, Catalano M, Bellodi L. An association between 5-HTTLPR polymorphism, COMT polymorphism, and Tourette's syndrome. Psychiatry Res.2000;97:93-100.
85. Kim SJ, Lee HS, Kim CH. Obsessive-compulsive disorder, factor-analyzed symptom dimensions and serotonin transporter polymorphism. Neuropsychobiology. 2005;52:176-162.
86. Hasler G, Kezuba D, Murphy DL. Factor analysis of obsessive-compulsive disorder Y-BOCS-SC symptoms and association with 5-HTTLPR SERT polymorphism. Am J Med Genet B Neuropsychiatr Genet. 2006;141:403-408.
87. Karayiorgou M, Sobin C, Blundell ML, et al. Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder. Biol Psychiatry. 1999;45:1178-1189.
88. Kinnear C, Niehaus DJ, Seedat S, et al. Obsessive-compulsive disorder and a novel polymorphism adjacent to the oestrogen responseelement (ERE 6) upstream to the COMT gene. Psychiatr Genet. 2001;11:85-87
89. Fisher PL, Wells A. How effective are cognitive and behavioral treatments for obsessive-compulsive disorder? A clinical significance analysis. Behav Res Ther. 2005;43:1543-1558.
90. Braga DT, Cordioli AV, Niederauer K, Manfro GG. Cognitive-behavioral group therapy for obsessive-compulsive disorder: a 1-year follow-up. Acta Psychiatr Scand. 2005;112:180-188.
91. Huppert JD, Franklin ME. Cognitive behavioral therapy for obsessive-compulsive disorder: an update. Curr Psychiatry Rep. 2005;7:268-273.
92. van Oppen P, van Balkom AJ, de Haan E, van Oyck R. Cognitive therapy and exposure in vivo alone and in combination with fluvoxamine in obsessive-compulsive disorder: a 5-year follow-up. J Clin Psychiatry. 2005;68:1415-1422.
93. Kampman M.,Kaijsers GP, Hoogduin CA, Verbraak MJ. Addition of cognitive-behaviour therapy for obsessive-compulsive disorder patients non-responding to fluoxetine. Acta Psychiatr Scand. 2002;106:314-319.
94. Marazziti D, Pfanner C, Del'Osso B, et al. Augmentation strategy with olenzapine in resistant obsessive compulsive disorder: an Italian long-term open-label study. J Psychopharmacol. 2005;19:392-394.
95. Fineberg NA, Sivakumaran T, Roberts A, Gale T. Adding quetiepine to SRI in treatment-resistant obsessive-compulsive disorder: a randomized controlled treatment study. Int Clin Psychopharmacol. 2005;20:223-226.
96. Schruers K, Koning K, Luermans J. Haack MJ, Griez E. Obsessive-convulsive disorder: a critical review of therapeutic perspectives. Acta Psychiatr Scand. 2005;111:261-271.
97. Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry. 2006;11:622-632.
98. Di Bella D, Cavallini MC, Bellodi L. No association between obsessive-compulsive disorder and the 5-HT(10beta) receptor gene. Am J Psychiatry. 2002;159:1783-1785.
99. Billett EA, Richter MA, King N, Heils A, Lasch KP, Kennedy JL. Obsessive compulsive disorder, response to serotonin reuptake inhibitors and the serotonin transporter gene. Mol Psychiatry. 1997;2:403-406.